Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease… Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease Treatment Yuhan Corporation has…
Leclaza Combination Therapy Study Published in NEJM, Raising Expectations for FDA… A study demonstrating the superior efficacy of the combination therapy of Yuhan Corporation's non-small cell lung cancer…
SK Bioscience CEO Jae-Yong Ahn: “Acquisition of Germany’s IDT Gains Us Five Crucial… Ahn Jae-Yong, CEO of SK Bioscience, highlighted the strategic importance of acquiring German contract manufacturing…